MYD88 and neoplasm: ,33 Anti-tumor immune cells such as CD8+ T cells and M1 macrophages showed higher activation in MyD88 and JAK/STAT signaling pathways closer to the tumor front, whereas immunoregulatory cell populations, such as M2 macrophages, regulatory T cells, and dendritic cells showed higher activation in the stroma.